How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

POSCO Holdings Inc.’s PKX unit POSCO Future M has invested in a U.S.-based all-solid-state battery company, Factorial, further strengthening the partnership that was entered into following the MOU ...

Recursion Pharmaceuticals (RXRX) shares recently closed at US$3.98, with the stock showing a negative return over the past month and past 3 months, which may prompt investors to reassess its current ...

Solid-state EV batteries, deemed the “holy grail” of battery tech, are moving from the lab to reality, even in the US. Factorial launches solid-state battery program in the US Factorial Energy has ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Posco Future M has invested in US-based battery cell maker Factorial as part of its efforts to gain an edge in the all-solid-state battery market, the company said Tuesday. The Korean battery ...

Posco Future M, the battery materials subsidiary of South Korea’s steel and chemicals firm Posco Group, announced it has made a strategic investment in Factorial Inc, a US-based developer of materials ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...